About ORIX Venture Finance
ORIX Venture Finance provides customized financial solutions up to $50 million in capital per transaction to mid- and late-stage companies which have established customers and run-rate revenues of $10 million or greater. Since its inception in 2001, ORIX Venture Finance has invested in more than 90 growth companies throughout the U.S. and Canada. www.orixventurefinance.com. ORIX USA is a Dallas, Texas-based financial services and investment firm with more than 1,400 employees and primary offices in Dallas, New York, Los Angeles, Columbus and Minneapolis. ORIX USA holds approximately $6 billion of assets and manages through various subsidiaries an additional $25 billion. www.orix.com. ORIX USA is a wholly owned subsidiary of ORIX Corporation, a Tokyo-based, publicly owned international financial services company with operations in 27 countries worldwide. ORIX Corporation is listed on the Tokyo (8591) and New York Stock Exchanges (IX).
About Primcogent Solutions
Primcogent Solutions is dedicated to offering healthcare products and services to the medical community backed by a clear, logical and convincing scientific and clinical foundation. Primcogent Solutions’ signature product, ZERONA, manufactured by Erchonia Medical is the only platform that is FDA cleared for the safe and effective simultaneous reduction of fat from the hips, waist and thighs. Primcogent Solutions’ revolutionary non-invasive body contouring technology, along with its unique physician business model, enhances practice profitability by eliminating the risks associated with purchasing capital equipment. For more information, visit http://www.primcogent.com.